Fresenius SE & Co. KGaA buy gerihouse
Summary
This prediction ended on 30.09.19 with a price of €44.07. With a performance of -4.21%, the BUY prediction by gerihouse finished with a loss. gerihouse has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fresenius SE & Co. KGaA | 1.712% | 1.712% | 6.591% | -31.245% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
Comments by gerihouse for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
Gesundheit
Das Analysehaus Warburg Research hat die Einstufung für Fresenius auf "Buy" mit einem Kursziel von 65 Euro belassen. Die Dialysetochter FMC sei gut auf die im US-Gesundheitssystem geplante Steigerung von Heimdialysebehandlungen für Patienten mit dauerhaftem Nierenversagen vorbereitet, schrieb Analyst Ulrich Huwald in einer am Donnerstag vorliegenden Studie.
Stopped prediction by gerihouse for Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
08.07.21
08.07.22
08.07.22
Fresenius SE & Co. KGaA
30.09.19
12.10.19
12.10.19
Fresenius SE & Co. KGaA
20.02.19
24.05.19
24.05.19
Fresenius SE & Co. KGaA
04.11.14
11.12.14
11.12.14
Fresenius SE & Co. KGaA
07.01.13
31.01.13
31.01.13
Fresenius SE & Co. KGaA
02.11.11
20.01.12
20.01.12